UF Health Cancer Center Support Grant - Training Navigator Supplement
UF Health Cancer Center Support Grant - Training Navigator Supplement
批准号:
10892335
负责人:
Jonathan D. Licht
金额:
$19.59万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
已结题
起止时间:
2023-06-01 至 2024-05-31
关键词:
AddressAdministrative SupplementAwardAwarenessBehavioral SciencesCaliforniaCancer CenterCancer Center Support GrantCaringCatchment AreaDevelopmentDiverse WorkforceEducationEducational workshopEvaluationExhibitsFloridaFundingGoalsGrantHealthHybridsIndividualLearningMalignant NeoplasmsMeasuresMentorshipMissionMonitorOnline SystemsOutcomePathway interactionsPostdoctoral FellowPreparationProductivityPublic HealthPublicationsResearch PersonnelResearch TrainingSeriesSystemTrainingUnderrepresented MinorityUnited States National Institutes of HealthUniversitiesWorkWritinganticancer researchcancer health disparitycareer developmenteducation researchhealth equityimprovedinnovationminority disparityminority traineeminority undergraduatenext generationpre-doctoralprogramsrecruitsuccesssymposium
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The University of Florida Health Cancer Center (UFHCC) recognizes that achieving health equity requires
inclusive education, training, recruitment, retention, and promotion of the next generation of cancer researchers.
Therefore, this Administrative Supplement application aims to recruit and develop a cadre of independent
researchers prepared to address cancer disparities in our catchment area. This supplement will enhance the
synergistic impact of CaRTEC, DEI, and the Florida-California Cancer Research, Education and Engagement
(CaRE2) Health Equity Center by focusing on developing underrepresented minority (URM) pre-doc, post-doc,
and early-stage investigators (ESIs). To expand upon the success of CaRTEC and CaRE2, and achieve their
long-term goal of improving training outcomes of URM trainees and ESIs, a Training Navigator Team (TNT) will
be implemented to 1) bridge activities between CaRTEC, DEI, and CaRE2 programs at the UFHCC; 2) facilitate
the entry of URM into the cancer research training pipeline; and 3) prepare trainees and ESIs to pursue career
development opportunities provided by the Center to Reduce Cancer Health Disparities CURE program and
beyond. This collaborative effort seeks to build upon the successes of each program through the following
objectives: 1) implement a TNT to attract, recruit, and support competitive underrepresented trainees and ESIs,
and facilitate their entry into NIH-supported pathway programs at the UFHCC and the attainment of NCI funding;
2) provide professional preparation and networking opportunities for scholars through grant writing and technical
assistance workshops (TAWs); and 3) monitor, track, and evaluate the progress and productivity of trainees and
ESIs. In particular, the TNT will help recruit URM trainees regionally, from partnering MSIs, as well as national
conferences to exhibit the work of minoritized undergraduate researchers. In addition, a series of 5 training
assistance workshops (TAWs) will be developed to prepare trainees and ESIs to pursue CURE funding. All
TAWs will be recorded and content will be used to develop an innovative hybrid and asynchronous course that
will be offered through the University's web-based learning management system. Metrics will be tracked on new
cancer-relevant awards and publications, proposals and supplements submitted and the corresponding funding
rate, and mentorship activities for trainees. Evaluations using the CPACHE U54 Research Education Shared
Measures Toolkit will also determine the impact of proposed activities on funding and career development. This
application is significant because it will increase the number of URM trainees at the UFHCC, increase the
awareness around URM- and cancer disparities-relevant funding, and improve the capacity for URM UFHCC
trainees to pursue external funding. This program will be impactful because it will help recruit >15 post-bacs,
pre-docs, post-docs, and fellows and will engage >40 pre-docs, post-docs, fellows, and ESIs in TAWs who will
submit a total of 10 CURE-supported applications in 2023-2024.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1042/bst20210567
发表时间:
2023-10-31
期刊:
Biochemical Society transactions
影响因子:
3.9
作者:
[]
通讯作者:
Exploring microRNA degradation in T-cell acute lymphoblastic leukemia
-
批准号:10717486
-
项目类别:
-
资助金额:$50.38万
-
财政年份:2023
-
负责人:Jonathan D. Licht
-
依托单位:
University of Florida Health Cancer Center Support Grant
-
批准号:10625750
-
项目类别:
-
资助金额:$213.5万
-
财政年份:2023
-
负责人:Jonathan D. Licht
-
依托单位:
Developmental Funds
-
批准号:10625759
-
项目类别:
-
资助金额:$30.5万
-
财政年份:2023
-
负责人:Jonathan D. Licht
-
依托单位:
Leadership, Planning, and Evaluation
-
批准号:10625761
-
项目类别:
-
资助金额:$42.28万
-
财政年份:2023
-
负责人:Jonathan D. Licht
-
依托单位:
Defining and targeting epigenetic plasticity-driven drug resistance and immune escape in melanoma
-
批准号:10666665
-
项目类别:
-
资助金额:$47.85万
-
财政年份:2022
-
负责人:Jonathan D. Licht
-
依托单位:
KDM6A mutation as an epigenetic driver of multiple myeloma
-
批准号:10229675
-
项目类别:
-
资助金额:$5.7万
-
财政年份:2020
-
负责人:Jonathan D. Licht
-
依托单位:
2019 Cancer Genetics and Epigenetics GRC/GRS
-
批准号:9754282
-
项目类别:
-
资助金额:$0.4万
-
财政年份:2019
-
负责人:Jonathan D. Licht
-
依托单位:
The Role of MMSET in the Pathogenesis and Progression of Lymphoid Malignancy
-
批准号:9330809
-
项目类别:
-
资助金额:$34.88万
-
财政年份:2016
-
负责人:Jonathan D. Licht
-
依托单位:
The Role of MMSET in the Pathogenesis and Progression of Lymphoid Malignancy
-
批准号:9759647
-
项目类别:
-
资助金额:$33.84万
-
财政年份:2016
-
负责人:Jonathan D. Licht
-
依托单位:
Spatio-Temporal Organization of Chromatin and Information Transfer in Cancer
-
批准号:8866966
-
项目类别:
-
资助金额:$198.95万
-
财政年份:2015
-
负责人:Jonathan D. Licht
-
依托单位:
Project 2: Molecular Modulation of Chromatin and Nuclear Structure in Cancer
-
批准号:8866971
-
项目类别:
-
资助金额:$52.07万
-
财政年份:2015
-
负责人:Jonathan D. Licht
-
依托单位:
Spatio-Temporal Organization of Chromatin and Information Transfer in Cancer
-
批准号:9070573
-
项目类别:
-
资助金额:$207.45万
-
财政年份:2015
-
负责人:Jonathan D. Licht
-
依托单位:
UTX, MLL and Pathogenic Deregulation of Histone Methylation in Multiple Myeloma
-
批准号:8916053
-
项目类别:
-
资助金额:$5.14万
-
财政年份:2014
-
负责人:Jonathan D. Licht
-
依托单位:
UTX, MLL and Pathogenic Deregulation of Histone Methylation in Multiple Myeloma
-
批准号:8775116
-
项目类别:
-
资助金额:$37.3万
-
财政年份:2014
-
负责人:Jonathan D. Licht
-
依托单位:
UTX, MLL AND PATHOGENIC DEREGULATION OF HISTONE METHYLATION IN MULTIPLE MYELOMA
-
批准号:9353181
-
项目类别:
-
资助金额:$34.74万
-
财政年份:2014
-
负责人:Jonathan D. Licht
-
依托单位:
Transcriptional Functions and Targets of the MMSET Protein of t(4:14) Myeloma
-
批准号:7754697
-
项目类别:
-
资助金额:$31.64万
-
财政年份:2009
-
负责人:Jonathan D. Licht
-
依托单位:
Transcriptional Functions and Targets of the MMSET Protein of t(4:14) Myeloma
-
批准号:8206815
-
项目类别:
-
资助金额:$30.69万
-
财政年份:2009
-
负责人:Jonathan D. Licht
-
依托单位:
Transcriptional Functions and Targets of the MMSET Protein of t(4:14) Myeloma
-
批准号:7583854
-
项目类别:
-
资助金额:$31.64万
-
财政年份:2009
-
负责人:Jonathan D. Licht
-
依托单位:
Transcriptional Functions and Targets of the MMSET Protein of t(4:14) Myeloma
-
批准号:8006402
-
项目类别:
-
资助金额:$30.69万
-
财政年份:2009
-
负责人:Jonathan D. Licht
-
依托单位:
Transcriptional Functions and Targets of the MMSET Protein of t(4:14) Myeloma
-
批准号:8403653
-
项目类别:
-
资助金额:$28.85万
-
财政年份:2009
-
负责人:Jonathan D. Licht
-
依托单位:
海外基金